Filing Details

Accession Number:
0001209191-21-060523
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-15 12:26:50
Reporting Period:
2021-10-07
Accepted Time:
2021-10-15 12:26:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1626878 Xbiotech Inc. XBIT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1639078 John Simard 5217 Winnebago Lane
Austin TX 78744
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-10-07 39,286 $12.45 3,923,166 No 4 S Direct
Common Stock Disposition 2021-10-12 18,000 $12.77 3,973,166 No 4 S Direct
Common Stock Disposition 2021-10-13 10,875 $12.83 3,962,452 No 4 S Direct
Common Stock Disposition 2021-10-14 21,125 $12.90 3,873,166 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.